PDLA ANNOUNCES RESIGNATION OF DIRECTOR AND ELECTION OF NEW CHAIRMAN OF THE BOARD
PDLA ANNOUNCES RESIGNATION OF DIRECTOR AND ELECTION
OF NEW CHAIRMAN OF THE BOARD
SOUTH PLAINFIELD, N.J., Nov. 7 /PRNewswire/ -- Princeton Diagnostic Laboratories of America, Inc. (AMEX: PDA) (PDLA) announced today that Robert J. Coleman resigned as a director of PDLA effective as of Oct. 29, 1991. Coleman had served as chairman of the board of directors until Oct. 22, 1991, at which time George M. Duff, Jr., a partner at the New York law firm of Holtzmann, Wise & Shepard, was elected as chairman of the board.
In addition to processing toxicology samples under Federal Guidelines (National Institute of Drug Abuse), PDLA provides specialized clinical testing relating to the detection and monitoring of the treatment of psychiatric disorders, drug abuse, AIDS, and other illnesses for private psychiatric hospitals, general hospitals, psychiatrists, clinical laboratories, sports teams, associations, and operating companies.
These tests are also used by major corporations, including 12 percent of the top 50 industrial companies of the Fortune 500, for diagnostic pre-employment screening.
/CONTACT: Pat Pikus or Frank Thiry of Princeton Diagnostic Laboratories of America, 908-769-8500/
(PDA) CO: Princeton Diagnostic Laboratories of America Inc. ST: New Jersey IN: SU: PER TS-SM -- NY055 -- 2236 11/07/91 12:44 EST